Understanding the causes and risks of postpartum depression
Disentangling the Epidemiologic and Genetic Heterogeneity of Postpartum Depression to Predict Risk and Prognosis
This study is looking at postpartum depression, which many new moms experience, to understand its different types and the genetic factors involved, so we can create better ways to predict and treat it for healthier outcomes for both moms and their babies.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10652450 on NIH RePORTER |
What this research studies
This research investigates postpartum depression (PPD), a common condition that affects new mothers and can have serious consequences for both mothers and their children. By analyzing data from large global studies, the research aims to identify different subtypes of PPD and their genetic factors. The study uses advanced statistical methods to explore how these subtypes can predict long-term mental health outcomes. Ultimately, the goal is to develop personalized risk prediction models that could lead to better prevention and treatment strategies for PPD.
Who could benefit from this research
Good fit: Ideal candidates for this research include new mothers experiencing symptoms of postpartum depression or those at risk for developing it.
Not a fit: Patients who are not new mothers or who do not experience postpartum depression are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention and treatment options for postpartum depression, improving outcomes for mothers and their children.
How similar studies have performed: Previous research has shown promise in identifying genetic and epidemiological factors related to postpartum depression, suggesting that this approach could yield valuable insights.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Bauer, Anna Elizabeth — Univ of North Carolina Chapel Hill
- Study coordinator: Bauer, Anna Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.